<DOC>
	<DOCNO>NCT00333099</DOCNO>
	<brief_summary>The aim study investigate enteral immunonutrition head neck esophageal cancer patient , use arginine , omega 3 fatty acid , nucleotides-enhanced diet [ Impact ( R ) , Novartis ] versus standard enteral nutrition ( control , Novartis ) , could improve clinical outcome ( mucositis frequency , treatment tolerance ) , nutritional immune status , life quality parameter .</brief_summary>
	<brief_title>INEC Study : Immuno-modulating Enteral Nutrition Cancer</brief_title>
	<detailed_description>Malnutrition frequent head neck ( H &amp; N ) esophageal cancer alters immune status , anti-infectious anti-tumoral defense response treatment ( surgery , chemotherapy , radiotherapy ) . Treatment 2 type cancer often chemoradiotherapy frequently induces mucositis . Mucositis enhance nutritional risk could impose modification interruption treatment . The aim study investigate enteral immunonutrition head neck esophageal cancer patient , use arginine , omega 3 fatty acid , nucleotides-enhanced diet [ Impact ( R ) , Novartis ] versus standard enteral nutrition ( control , Novartis ) , could improve clinical outcome ( mucositis frequency , treatment tolerance ) , nutritional immune status , life quality parameter .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Malnutrition</mesh_term>
	<criteria>H &amp; N esophageal cancer patient , treat surgery need chemoradiotherapy Performance status : Objective Mucositis Score ( OMS ) 0 , 1 , 2 Karnofsky &gt; 50 % Acceptance gastrostomy , jejunostomy nasogastric tube conduct enteral nutrition Informed consent form sign H &amp; N cancer treat exclusive radiotherapy H &amp; N esophageal cancer treat exclusive surgery Tonsil cancer Existence metastases Concomitant cancer Repeat cancer site Insulin dependant diabetes Thyroid diseases Subjects major surgery severe infectious status 3 precede month Biological assessment incompatible esophagus chemotherapy treatment ( polynuclear cell &lt; 1500/ml ; blood platelet &lt; 100000/ml ; serum creatinine &gt; 130 Âµmol/ml ; ASAT , ALAT , ALP bilirubin &gt; twice norm ) Patients take food supplement enrich omega 3 ( arginine nucleotide ) , period study precede month Breast feeding woman period fertility without effective mean contraception Patients refuse participate unable receive information unable sign write informed consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Enteral nutrition</keyword>
	<keyword>immunonutrients</keyword>
	<keyword>head neck cancer</keyword>
	<keyword>esophageal cancer</keyword>
	<keyword>chemoradiotherapy</keyword>
	<keyword>H &amp; N esophageal cancer patient chemoradiotherapy treatment .</keyword>
</DOC>